Navigation Links
Sundia Receives 2011 Zero2IPO Venture 50 Award
Date:11/21/2011

SHANGHAI, Nov. 21, 2011 /PRNewswire-Asia/ -- Sundia MediTech Company Inc., a leading pharmaceutical Contract Research Organization (CRO) in China, announced that the company was named one of the 50 best companies for investment in China in 2011 by Zero2IPO. The news was announced at an October ceremony in Shanghai. This is the third time for Sundia to get this prestigious award after it was previously named in 2007 and 2008.

Zero2IPO-Venture 50 was launched by Zero2IPO Group in 2006. Until now it has become the highest level of enterprise appraisal by venture capitalists in China, and reflects the enterprise with the most potential. The 50 enterprises with the most investment value were selected from a pool of thousands of nominated companies in leading industries by evaluating nominees' business on management team, ownership structure, business model, competitiveness, industry and market, financial situation and forecast, management risks and strategy.

Sundia was founded in 2004 in Shanghai by a group of biotech and pharmaceutical industry veterans from North America. The company has provided integrated R&D outsourcing services to biotech and pharmaceutical clients worldwide. Over the past 7 years, Sundia has successfully established collaborations with over 100 clients in North America, Europe, Japan, Korea and China. Now, Sundia has become a top CRO company in China with 700 employees with operations in Shanghai and Shijiazhuang, the capital city of Hebei Province in Northern China.

Dr. Xiaochuan Wang, Chairman of Sundia attended the ceremony and made a reception speech. "We really appreciate the venture investor for voting Sundia into Venture 50 again. It is recognition of the effort of all of our team members," she acknowledged.


'/>"/>
SOURCE Sundia MediTech Company Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. Amsterdam Molecular Therapeutics Receives Orphan Designation in the European Union for Hemophilia B Gene Therapy
2. Vascular Designs, Inc. Receives CE Mark Approval for Its IsoFlow™ Infusion Catheter to Target Cancerous Tumors
3. Qualitest Pharmaceuticals Receives FDA Approval for Acetaminophen and Codeine Phosphate Oral Solution USP, 120mg/12mg per 5mL
4. First Patient Receives FDA-Approved Telescope Implant for End-Stage Macular Degeneration
5. Ethicon Endo-Surgery Receives 510(k) Clearance for New ENSEAL® G2 Curved and Straight Tissue Sealers Line -- Broadest Range of Advanced Bipolar Tissue Sealers Available for Open and Minimally Invasive Surgery
6. Nephros Receives Initial FDA Response to 510(k) Application for Hemodiafiltration System
7. IDEV Technologies Receives FDA Clearance for Its SUPERA VERITAS® 6 French Stent Delivery System
8. Augurix Diagnostics Receives the 2011 Debiopharm /Valais Award for its Point-of-care Diagnostic Test for the Early Detection of Celiac Disease
9. The Childrens Hospital of Philadelphia Receives Grand Challenges Explorations Funding
10. Femasys Receives FDA 510(k) Clearance for First Low Pressure HSG Device
11. PTC Therapeutics Receives Grand Challenges Explorations Funding
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/20/2017)... WOONSOCKET, R.I. , April 20, 2017 /PRNewswire/ ... (NYSE: CVS), today unveiled a new store design ... new assortment of healthier food, health-focused products and ... the store to help customers discover new offerings. ... represent the next evolution of the customer experience ...
(Date:4/20/2017)... April 20, 2017 NeuroVive Pharmaceutical AB ... announced positive preclinical results demonstrating anti-fibrotic effects ... non-alcoholic steatohepatitis (NASH), in an additional well-validated ... NV556 has previously shown similar anti-fibrotic effects ... NeuroVive,s scientists present novel data demonstrating anti-fibrotic ...
(Date:4/19/2017)... , April 19, 2017  IRIDEX Corporation (Nasdaq: ... financial results for the first quarter 2017 after the ... Company,s management team will host a corresponding conference call ... Investors interested in listening to the conference ... domestic callers or (703) 326-3030 for international callers, using ...
Breaking Medicine Technology:
(Date:4/28/2017)... ... 2017 , ... Ushio America proudly introduces the new ... solution for F32T8 fluorescent lamps on most instant-start and programmed-start electronic ballasts so ... lamps utilize the existing electronic ballast, saving labor and maintenance costs. It’s easy ...
(Date:4/28/2017)... Md. (PRWEB) , ... April 28, 2017 , ... ... Association of America (UCAOA) and College of Urgent Care Medicine will host industry ... workshops, sessions and speakers will help those in the industry adapt to the ...
(Date:4/28/2017)... ... April 28, 2017 , ... Researchers at ... ActiGraph’s CentrePoint Data Hub in a sample of participants enrolled in ... activity and sleep monitoring solutions for the global scientific community. The company’s new ...
(Date:4/28/2017)... ... 28, 2017 , ... Rob Lowe is a popular actor that has been ... to an educational purpose as the host of the “Informed” series. The program focuses ... recent episode, the series focuses on thyroid cancer. , Although thyroid cancer is an ...
(Date:4/27/2017)... ... April 27, 2017 , ... Healthcare companies are trying ... will rapidly reject an outdated healthcare executive resume. , “If you’re a healthcare executive ... executive resume and wondering if it’s as ready as you are for a new ...
Breaking Medicine News(10 mins):